David Probert takes up position as Moorfields' new chief executive

David Probert took up his new role as Moorfields’ new chief executive on 18 April 2016. David is the former director of strategic development at University College London Hospitals NHS Foundation Trust, where he has led the development of a number of major strategic initiatives including two major hospital developments on the UCLH site.

David’s previous roles include the chief operating officer at the Royal Marsden NHS Foundation Trust, where he had board level responsibility for all clinical and non-clinical NHS and commercial services, both within the hospital and across the communities of Sutton and Merton. He has also held a number of senior operational leadership positions at Guy’s and St Thomas’ NHS Foundation Trust.

David said: “I am honoured to begin my role as chief executive and to join the team at Moorfields. I am looking forward to progressing a number of major initiatives to help define the hospital’s exciting future.” 

Notes to editors

  • Moorfields is one of the world’s leading eye hospitals, providing expertise in clinical care, research and education. We have provided excellence in eye care for more than 200 years and we continue to be at the forefront of new breakthroughs and developments. We are an integral part of one of the UK’s first academic health science centres, UCL Partners, and also one of the new academic health science networks. We were one of the first NHS organisations to achieve foundation trust status in 2004.
  • We treat the entire range of eye diseases, from common complaints to rare conditions which require treatments not available anywhere else in the UK. We dealt with more than 470,000 patient attendances in 2013/14 across our locations in and around London, enabling us to provide expert care closer to patients’ homes.
  • Our specialist A&E dealt with almost 90,000 patient visits in the year 2013/14.

  • With our academic partners at the UCL Institute of Ophthalmology, Moorfields is recognised as a leading centre of excellence in eye and vision research. Together, we form one of the largest ophthalmic research sites in the world, with the largest patient population in Europe or the USA. We publish more scientific papers than any other eye and vision research site, and have an extensive joint research portfolio.

Was this information useful? Please rate the page.